Printer Friendly

Incidence of virulence determinants in clinical Enterococcus faecalis and Enterococcus faecium isolates collected in Bulgaria.

Introduction

Enterococci (mostly Enterococcus faecalis and Enterococcus faecium) are natural inhabitants of the gastrointestinal tract of humans and animals, (1) but are also found in other anatomical sites, including the vagina and oral cavity, (2) and in the soil, water, plants, and food. (3-5) Several reports have documented that the two most important species are among the leading causes of opportunistic human infections, (6) including urinary tract infections, (7) infections of the surgical site and burn wound infections, (8,9) bacteremia and sepsis, (10) endocarditis, (11) cholecystitis, (12) peritonitis, (13) neonatal meningitis, (14) and others.

The severe infections caused by Enterococcus spp. are difficult to treat due to the organism's capacity to survive in the hospital environment, their intrinsic resistance to many antimicrobials, their remarkable ability to acquire further resistance mechanisms toward strategic antibiotics during the treatment period and a variety of virulence factors. (15)

Virulence factors contribute to the pathogenesis of enterococcal infections through mediation of adhesion, colonization and invasion into the host tissues, modulation of the host immunity, and extracellular production of enzymes and toxins, which enhance the severity of the infection. (16) Many virulence factors, such as the enterococcal surface protein (Esp), aggregation substance, capsule formation and gelatinase, are involved in bacterial adherence to host cells and/or in biofilm formation on abiotic surfaces in hospital environment. (17-21) Biofilm production has an important role in the pathogenesis of enterococcal infections and also favors disease sustenance because of restricted penetration of antimicrobials. (19) Invasion is usually facilitated by damage to host tissues and presence of virulence factors, including hyaluronidase and gelatinase, which assist in the advancement and further survival in newly infected places. (21)

Currently, our knowledge about the possible relationship between the presence of virulence factors and their implication in human enterococcal infections is still limited.

The aim of the present study was to examine the prevalence of genes encoding cell-associated and extracellular virulence factors in clinically relevant isolates of Enterococcus spp. and to assess the association of those genes with species, infection site, and patient population (inpatients or outpatients).

Materials and methods

Bacterial isolates

A collection of 510 non-duplicate clinical strains of Enterococcus spp., causing symptomatic infections, was investigated. All urinary tract infections were associated with significant bacteriuria ([greater than or equal to] [10.sup.5] CFU/mL). The isolates were recovered between June 2013 and June 2015 from 398 inpatients and 112 outpatients in seven large Bulgarian hospitals. They were obtained from urine (n = 256), surgical wound or abscesses (n= 138), genital tract samples (n = 74), blood (n = 26), peritoneal fluid (n = 6), lower respiratory tract samples (n = 8), and bile (n = 2). E. faecalis ATCC 29212 and E. faecium ATCC 19434 were used as control strains for species identification with biochemical and molecular genetic techniques.

Culture media

HiCrome E. faecium Agar Base (Himedia Labs) was applied to isolate Enterococcus spp. strains. E. faecalis forms blue colonies, while E. faecium gives green colonies, surrounded by yellowish coloring of the ambient.

Biochemical identification with commercial kits and systems

Species identification was done using API Rapid ID 32 Strep (bioMerieux), BBL Crystal Gram-positive ID kit (Becton Dickinson) and the automated system VITEK 2 (bioMerieux).

DNA isolation

Total DNA from all used strains was extracted with GenElute[TM] Bacterial Genomic DNA Kit (Sigma-Aldrich), according to the manufacturer's instructions, from 3 mL overnight cultures inoculated with a single colony.

Molecular genetic genus and species identification

Polymerase chain reaction (PCR) amplification of the 16S rRNA gene of Enterococcus spp. was used for genus identification of all isolates included in this study. The sodA genes encoding the enzyme manganese-dependent superoxide dismutase in the most common enterococci (E. faecalis, E. faecium and Enterococcus durans) were detected with multiplex PCR. E. faecalis identification was confirmed by PCR for the eda1 gene (encoding 2-keto-3-deoxy-6-phosphogluconate aldolase, which is an enzyme involved in the Entner-Doudoroff pathway and is species-specific for E. faecalis). Oligonucleotides used as primers and amplification conditions were previously described. (22)

PCR assay for detection of virulence genes

PCR amplification was performed in order to confirm the presence of genes coding for different virulence factors: adhesins (aggregation substance--agg and asa1 of E. faecalis and E. faecium, respectively), enterococcal surface protein (esp for both species), endocarditis-specific antigen A (efaA for both species), collagen-binding proteins (ace/acm); invasins (extracellular metalloendopeptidase also called gelatinase--gelE for both species, hyaluronidase--hyl for both species); cytotoxines (activation of cytolysin (class I. bacteriocin)--cylA in E. faecalis) and modulators of the host immunity and inflammation (sex pheromones--enhanced expression pheromone, eep in E. faecalis). Oligonucleotides used for specific amplification primers (Alpha DNA) were previously published in the literature (23-29) and are shown in eTable 1 (see the E-supplemental material).

Supplementary Table 1 related to this article can be found, in the online version, at http://dx.doi.org/10.1016/ j.bjid.2015.11.011.

PCR was carried out with 2 [micro]L template DNA, 0.25 of each primer, 0.2 mM deoxyribonucleoside triphosphates, 1x reaction buffer, 2mM Mg[Cl.sub.2] and 0.5 U Prime Taq DNA polymerase (Genet Bio) in a total volume of 25 [micro]L. The DNA was amplified in Gene Pro Thermal Cycler (Bioer) using the following protocol: initial denaturation (94[degrees]C for 5 min), followed by 25-30 cycles of denaturation (94[degrees]C for 35-45 s), annealing (50-68[degrees]C, from 45 s to 1 min) and extension (72[degrees]C, from 45 s to 1 min 35 s), with a single final extension of 7 min at 72[degrees]C. PCR products were separated in 1% agarose gel for 50-110 min at 130 V, stained with ethidium bromide (0.5 [micro]g/mL) and detected by UV transillumination (wavelength 312 nm). Amplified genes were identified on the basis of fragment size presented in eTable 1.

Statistical analysis

The distribution of virulence genes with respect to both species and isolate origin was compared using Student's t-test. For a simple comparison tests a p-value below 0.05 was considered statistically significant. In order to counteract the problem of multiple comparisons, when they were used, a Bonferroni correction with a critical value of p = 0.00625 was applied.

Results

Prevalence of virulence genes among all studied Enterococcus spp. isolates (n = 510)

The established overall frequencies of the studied genes encoding adhesins (esp, agg/asa1, ace/acm, efaA), modulators of the host immunity and inflammation (eep), invasins (gelE, hyl), and cytotoxins (cylA) were as it follows: 44.3%, 38.4%, 64.3%, 85.9%, 69.4%, 64.3%, 25.1%, and 47.1%.

[FIGURE 1 OMITTED]

Comparative prevalence of virulence genes among E. faecalis (n = 370) and E. faecium (n = 110)

The prevalence of virulence genes in the two species was esp--59.5% in E. faecalis and 4.3% in E. faecium (p < 0.001), agg/asa1--44.3% us. 22.8% (p < 0.001), ace/acm--61.1%/72.8%, efaA--84.9%/88.5%, gelE--82.2%/17.1% (p < 0.001), and hyl--25.3%/24.2%. eep was found in 95.7% of E. faecalis isolates and cylA in 64.9% (Fig. 1).

The genes associated with virulence potential of the studied E. faecalis and E. faecium isolates are shown in Tables 1A and 1B. It should be pointed out in these tables the significantly higher prevalence of E. faecalis with multiple virulence determinants (over 4) compared to E. faecium (71.9% us. 1.5%, p < 0.001), whereas isolates with only one determinant significantly prevailed in E. faecium compared to E. faecalis (50.0%/1.1%, p < 0.001).

Comparative prevalence of virulence genes in Enterococcus spp. with respect to the infection site

Table 2 lists the prevalence of virulence genes of all enterococci isolates, as well as the prevalence in each enterococcal species, broken down by the infection site. The following are the most important results found:

* The genes for some adhesins (esp; agg/asa1 and efaA) were significantly more prevalent among the non-invasive isolates of Enterococcus spp. (51.4% in genital tract infection (GTI) isolates, 39.1-59.5% in wound and GTI isolates, and 93.8% in urinary tract infection (UTI) isolates) compared to the invasive bacteremia isolates (respectively, 23.1%, 15.4%, and 61.5%) (p < 0.001-0.05), while ace/acm revealed a significantly higher frequency (p < 0.02-0.05) in invasive isolates (84.6%) compared to the non-invasive GTI and wound isolates (54.1% and 59.4%, respectively).

* For E. faecalis, agg was more frequent in isolates from the genital tract (57.1%) in comparison to the isolates from blood (22.2%)--p < 0.05, while efaA was more common in isolates from UTI (94.3%) us. from wound samples (72.9%)--p < 0.01.

* For E. faecium, there were no significant differences in the distributions of genes encoding virulence factors, according to the infection site, but isolates from blood stream infections (n = 8) were not considered due to their low number.

Comparative prevalence of virulence genes among Enterococcus spp. isolates obtained from inpatients (n = 398) and outpatients (n = 112) with symptomatic infections

Enterococcus spp. isolates from outpatients had significantly higher prevalence (p < 0.001-0.02) of the following virulence genes compared to the isolates from inpatients: agg/asa1 (58.9%/32.7%), eep (92.9%/62.8%), gelE (78.6%/60.3%), and cylA (73.2%/37.9%)--Fig. 2.

Discussion

In this study, we found a significantly higher prevalence (p < 0.001) of genes encoding some virulence factors involved in biofilm formation (the enterococcal surface protein (esp), aggregation substance (agg) and gelatinase (gelE)) in E. faecalis, compared to E. faecium. A previous study indicated higher prevalence of biofilm formation among E. faecalis strains compared to other enterococcal species. (30) E. faecalis has been recognized as the enterococcal species most commonly infecting indwelling medical devices. (17,30) In a study conducted by Dupre et al. with clinically relevant enterococcal isolates from a hospital in Sardinia, Italy, in the period of 1998-2001 there was a complete absence of genes for gelatinase and aggregation substance in E. faecium, but contrary to our results, higher frequency of esp in E. faecium us. E. faecalis was reported (71.9%/60%). (23)

The prevalence of efaA, eep, gelE, and cylA in E. faecalis isolates in our study was significantly higher than previously published data on clinical strains of E. faecalis from Brazil in 2004--as it follows: 84.9%/58.9%; 95.7%/58.9%; 82.2%/45.3%; 64.9%/16.8% (p < 0.001), while the gene frequency for agg and esp had similar rates in both studies (44.3%/36.8%, and 59.5%/57.9%). (29) Detection of genes for adhesins (esp, agg, ace and efaA) in newer clinical E. faecalis isolates from Southern Brazil was more frequent than the rates found in our study (respectively, 68.4% in Brazil us. 59.5% in our study, 57.9%/44.3%, 73.7%/61.1% and 100%/84.9%). In contrast, genes for gelE and cylA were more frequent in our isolates than among the Brazilian isolates (77.2%/82.2% and 54.4%/64.9%, respectively). (31) A recent study of clinical isolates of E. faecalis in Italy showed a significantly lower frequency of cylA compared to our isolates (26.4%/64.9%, p < 0.001), and close to our distribution of esp, agg, ace and efaA (52.7%/59.5%; 42.8%/44.3%; 67%/61.1%; 96.7%/84.9%). (32)

[FIGURE 2 OMITTED]

A multicenter study on the distribution of virulence determinants in fecal E. faecium isolates from patients in 13 hospitals from nine European countries showed total absence of asa1 and gelE, lower frequency of hyl in comparison to E. faecium isolates (17%/24.2%) of our study and significantly higher prevalence of esp (65% us. 4.3%, p < 0.001). (26)

The significantly higher prevalence of clinical E. faecalis isolates with multiple virulence determinants (over 4) compared to E. faecium, and the significant predominance of E. faecium isolates with one gene compared to E. faecalis, demonstrated in this study, was also recently found by Padmasini et al. (33) According to another study of enteroccoci from clinical isolates and starter cultures, all strains of E. faecalis were characterized by a high number of virulence genes (between 6 and 11), while the E. faecium strains had no such gene determinants. (25)

In Italy, Creti et al. reported wider distribution of esp in non-invasive E. faecalis isolates (56.2%) compared to invasive isolates (38.4%). (28) In our study esp was found in 33.3% of infections caused by E. faecalis, with bacteremia in the clinical course, while the frequency of esp in non-invasive infections varied from 54.3% (in GTIs) to 64.8% (in UTIs), which confirms the important role of Esp as a colonizing factor in UTIs. (34) The frequency of esp among our UTIE. faecalis isolates (64.8%) was very similar to the rate reported by Creti et al. (66.7%). The findings for cylA in both studies were similar: 44.4% in invasive isolates from bacteremia in our data us. 50% in the Italian study, as well as the results for cylA in non-invasive isolates --varying from 62.5% to 77.1% in our study and 62.5% in the Italian study.28

Recently Padilla et al. published their data on incidence of virulence genes amongst strains of E. faecalis isolated from UTIs and bacteremia in Chile, for the period of 2008-2009. (35) The rates for the following genes from urine samples in our study were significantly higher than those reported in Chile: efaA (94.3%/62%, p < 0.001), eep (98.9%/72%, p < 0.001), gelE (83%/28%, p < 0.001), cylA (62.5%/40%, p < 0.01); while the presence of agg was significantly lower (43.2%/78%, p < 0.001). Our isolates from bacteremia showed a significantly higher frequency of efaA compared to the Chilean isolates (66.7%/28%, p < 0.001).

E. faecalis isolates from patients with UTIs and wound infections in the present study showed higher prevalence of numerous virulence genes, compared to similar isolates from Brazil, studied by Bittencourt de Marques and Suzart--esp (64.9% and 60.4% us. 62% and 46.1%), agg (43.2% and 43.8%/38% and 38.5%), efaA (94.3% (p < 0.001) and 72.9%/54% and 69.2%), eep (98.9% (p < 0.001) and 93.8% (p < 0.001)/58% and 53.8%), gelE (83% (p < 0.001) and 81.3% (p < 0.001)/50% and 34.6%) and cylA (62.5% (p < 0.001) and 64.6% (p < 0.001)/22% and 3.8%). (29)

An interesting finding from the present study was the higher dissemination rates of gene determinants for some virulence factors among Enterococcus spp. causing infections in outpatients, compared to those infecting inpatients. The review of published medical literature could not find a similar comparative study. Hospitalized patients may have a greater incidence of enterococcal infections not only because of virulence, but because the hospital itself is a risky hub. On the other hand, the intestinal tract is an important reservoir for opportunistic pathogens such as enterococci and allows them to access infected sites especially in outpatients through different virulence factors. (21) A weakness of this comparative analysis results from the difficulties to obtain epidemiological data; often UTIs, occurring in inpatients, begin before admission to the hospital.

Conclusions

In the present study clinical E. faecalis isolates were characterized by a significantly higher frequency of genes encoding some adhesins and gelatinase in comparison to E. faecium isolates. The higher virulence potential of E. faecalis vs. E.faecium isolates was proven (on the basis of a significantly higher prevalence of E. faecalis isolates with multiple virulence factor genes vs. E. faecium and significant predominance of E. faecium isolates without or with only one gene compared to the E. faecalis).

The genes for some adhesins (esp and agg/asa1) were more prevalent in non-invasive Enterococcus spp. isolates than in invasive isolates from bacteremia, while ace/acm showed a significantly higher frequency among invasive isolates.

For the first time, we proved that Enterococcus spp. isolates from outpatients with symptomatic infections had significantly higher frequency of the following virulence genes: agg/asa1, eep, gelE and cylA, in comparison to isolates causing infections in inpatients.

To the best of our knowledge, this is the first study in Bulgaria and in the Balkans region of the genes associated cellular and extracellular virulence factors among clinically relevant Enterococcus spp. isolates, in which a comparative analysis with respect to different features (species of microorganism, infection site, and origin) was made. Our results may serve as a basis for additional research of the pathogenesis of infections caused by Enterococcus spp.

Conflicts of interest

The authors declare no conflicts of interest.

Acknowledgements

This work was supported by grants from the Medical University of Sofia, Bulgaria (Council of Medical Science, grant Nos. 16/2013 and 11/2014).

REFERENCES

(1.) Silva N, Igrejas G, Goncalves A, Poeta P. Commensal gut bacteria: distribution of Enterococcus species and prevalence of Escherichia coli phylogenetic groups in animals and humans in Portugal. Ann Microbiol. 2012;62:449-59.

(2.) Pabich WL, Fihn SD, Stamm WE, Scholes D, Boyko EJ, Gupta K. Prevalence and determinants of vaginal flora alterations in postmenopausal women. J Infect Dis. 2003;188:1054-8.

(3.) Byappanahalli MN, Nevers MB, Korajkic A, Staley ZR, Harwood VJ. Enterococci in the environment. Microbiol Mol Biol Rev. 2012;76:685-706.

(4.) Muller T, Ulrich A, Ott EM, Muller M. Identification of plant-associated enterococci. J Appl Microbiol. 2001;91:268-78.

(5.) Giraffa G. Enterococci from foods. FEMS Microbiol Rev. 2002;26:163-71.

(6.) Batistao DW, Gontijo-Filho PP, Conceicao N, Oliveira AG. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz. 2012;107:57-63.

(7.) Barros M, Martinelli R, Rocha H. Enterococcal urinary tract infections in a university hospital: clinical studies. Braz J Infect Dis. 2009;13:294-6.

(8.) Giacometti A, Cirioni O, Schimizzi AM, et al. Epidemiology and microbiology of surgical wound infections. J Clin Microbiol. 2000;38:918-22.

(9.) Falk PS, Winnike J, Woodmansee C, Desai M, Mayhall CG. Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol. 2000;21:575-82.

(10.) Suppli M, Aabenhus R, Harboe ZB, Andersen LP, Tvede M, Jensen JU. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy. Clin Microbiol Infect. 2011;17:1078-83.

(11.) McDonald JR, Olaison L, Anderson DJ, et al. Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. Am J Med. 2005;118:759-66.

(12.) Khardori N, Wong E, Carrasco CH, Wallace S, Patt Y, Bodey GP. Infections associated with biliary drainage procedures in patients with cancer. Rev Infect Dis. 1991;13:587-91.

(13.) Perez-Fontan M, Rodriguez-Carmona A, Rodriguez-Mayo M. Enterococcal peritonitis in peritoneal dialysis patients: last name matters. Perit Dial Int. 2011;31:513-7.

(14.) Breton JR, Peset V, Morcillo F, et al. Neonatal meningitis due to Enterococcus spp.: presentation of four cases. Enferm Infecc Microbiol Clin. 2002;20:443-7.

(15.) Mundy LM, Sahm DF, Gilmore M. Relationship between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev. 2000;13:513-22.

(16.) Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev 1994;7:462-78.

(17.) Oli AK, Raju S, Rajeshwari Nagaveni S, Kelmani CR. Biofilm formation by Multidrug resistant Enterococcus faecalis (MREF) originated from clinical samples. J Microbiol Biotechnol Res. 2012;2:284-8.

(18.) Toledo-Arana A, Valle J, Solano C, et al. The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol. 2001;67:4538-45.

(19.) Di Rosa R, Creti R, Venditti M, et al. Relationship between biofilm formation, the enterococcal surface protein (Esp) and gelatinase in clinical isolates of Enterococcus faecalis and Enterococcus faecium. FEMS Microbiol Lett. 2006;256:145-50.

(20.) Chuang-Smith ON, Wells CL, Henry-Stanley MJ, Dunny GM. Acceleration of Enterococcus faecalis biofilm formation by aggregation substance expression in an in vivo model of cardiac valve colonization. PLoS ONE. 2010;5:e15798.

(21.) Biswas PP, Dey S, Adhikari L, Sen A. Virulence markers of vancomycin resistant enterococc isolated from infected and colonized patients. J Glob Infect Dis. 2014;6:157-63.

(22.) Strateva T, Dimov SG, Atanasova D, Petkova V, Savov E, Mitov I. Molecular genetic study of potentially bacteriocinogenic clinical and dairy Enterococcus spp. isolates from Bulgaria. Ann Microbiol. 2015;65, http://dx.doi.org/10.1007/s13213-015-1120-3.

(23.) Dupre I, Zanetti S, Schito AM, Fadda G, Sechi LA. Incidence of virulence determinants in clinical Enterococcus faecium and Enterococcus faecalis isolates collected in Sardinia (Italy). J Med Microbiol. 2003;52:491-8.

(24.) Nallapareddy SR, Weinstock GM, Murray BE. Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol Microbiol. 2003;47:1733-44.

(25.) Eaton TJ, Gasson MJ. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol. 2001;67:1628-35.

(26.) Vankerckhoven V, Van Autgaerden T, Vael C, et al. Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol. 2004;42:4473-9.

(27.) Shankar V, Baghdayan AS, Huycke MM, Lindahl G, Gilmore MS. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun. 1999;67:193-200.

(28.) Creti R, Imperi M, Bertuccini L, et al. Survey of virulence determinants among Enterococcus faecalis isolated from different sources. J Med Microbiol. 2004;53:13-20.

(29.) Bittencourt de Marques E, Suzart S. Occurrence of virulence-associated genes in clinical Enterococcus faecalis strains isolated in Londrina, Brazil. J Med Microbiol. 2004;53:1069-73.

(30.) Ramadhan AA, Hegedus E. Biofilm formation and esp gene carriage in enterococci. J Clin Pathol. 2005;58: 685-6.

(31.) Medeiros AW, Pereira RI, Oliveira DV, et al. Molecular detection of virulence factors among food and clinical Enterococcus faecalis strains in South Brazil. Braz J Microbiol. 2014;45:327-32.

(32.) Cosentino S, Podda GS, Corda A, Fadda ME, Deplano M, Pisano MB. Molecular detection of virulence factors and antibiotic resistance pattern in clinical Enterococcus faecalis strains in Sardinia. J Prev Med Hyg. 2010;51:31-6.

(33.) Padmasini E, Divya G, Karkuzhali M, Padmaraj R, Ramesh SS. Distribution of cylA, esp, asa1, hyl and gelE virulence genes among clinical isolates of Enterococcus faecium and Enterococcus faecalis. BMC Infect Dis. 2014;14 Suppl. 3:P32.

(34.) Shankar N, Lockatell CV, Baghdayan AS, Drachenberg C, Gilmore MS, Johnson DE. Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun. 2001;69:4366-72.

(35.) Padilla EC, Nuirez MA, Padilla GA, Lobos GO. Genes de virulencia y bacteriocinas en cepas de Enterococcus faecalis aisladas desde diferentes muestras clinicas en la Region del Maule, Chile. Rev Chil Infect. 2012;29:55-61.

Tanya Strateva (a), *, Daniela Atanasova (a), Encho Savov (b), Guergana Petrova (c), Ivan Mitov (a)

(a) Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Bulgaria

(b) Laboratory of Microbiology, Department of Military Epidemiology and Hygiene, Military Medical Academy, Sofia, Bulgaria

(c) Pediatric Clinic, Alexandrovska University Hospital, Faculty of Medicine, Medical University of Sofia, Bulgaria

ARTICLE INFO

Article history:

Received 3 September 2015

Accepted 18 November 2015

Available online 2 February 2016

* Corresponding author at: Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia; 2 Zdrave Street, 1431 Sofia, Bulgaria.

E-mail address dr.strateva@abv.bg (T. Strateva).

http://dx.doi.org/10.1016/j.bjid.2015.11.011
Table 1A--Virulence potential (depending the number of
present virulence factor genes) in 370 E. faecalis
isolates from different infection sites.

Number of     Number (%) of isolates with the
virulence       respective number of genes
genes

              Urine       Wounds      Genital
            (n = 176)    (n = 96)    tract (a)
                                     (n = 70)

0            0 (0.0)      0 (0.0)     0 (0.0)
1            0 (0.0)      2 (2.1)     0 (0.0)
2-4         42 (23.9)    28 (29.2)   18 (25.7)
5-7         124 (70.5)   64 (66.7)   48 (68.6)
8            10 (5.7)     2 (2.1)     4 (5.7)

Number of     Number (%) of isolates with the
virulence       respective number of genes
genes

              Blood     Others (b)     Total
            (n = 18)     (n = 10)    (n = 370)

0            0 (0.0)     0 (0.0)      0 (0.0)
1            0 (0.0)     2 (20.0)     4 (1.1)
2-4         10 (55.6)    2 (20.0)    100 (27.0)
5-7          6(33.3)     6 (60.0)    248 (67.0)
8           2 (11.1)     0 (0.0)      18 (4.9)

(a) Genital tract specimens--sperm, urethral, vaginal
and cervical samples.

(b) Others--peritoneal fluid (n = 4), bile (n = 2) and
lower respiratory tract samples (n = 4).

Table 1B--Virulence potential (depending the
number of present virulence factor genes) in 140
E. faecium isolates from different infection
sites.

Number of   Number (%) of isolates with the
virulence   respective number of genes
genes

              Urine      Wounds      Genital
            (n = 80)    (n = 42)    tract (a)
                                     (n = 4)

0            12 (15)     2 (4.8)      0 (0)
1           30 (37.5)   14 (33.4)     0 (0)
2-4         38 (47.5)   24 (57.2)    4 (100)
5             0 (0)      2 (4.8)      0 (0)

Number of   Number (%) of isolates with the
virulence   respective number of genes
genes

             Blood    Others (b)     Total
            (n = 8)    (n = 6)     (n = 140)

0            0 (0)      0 (0)       14 (10)
1           6 (75)     6 (100)      56 (40)
2-4         2 (25)      0 (0)      68 (48.6)
5            0 (0)      0 (0)       2 (1.4)

(a) Genital tract specimens--sperm samples (n = 2)
and vaginal samples (n = 2).

(b) Others--peritoneal fluid (n = 2) and lower
respiratory tract samples (n = 4).

Table 2--Prevalence of virulence genes in 510
clinical Enterococcus spp. (370 E. faecalis and
140 E. faecium) isolates according to the site of
infection.

Gene                Number (%) of isolates with the respective gene

                    Urine                Wounds
                    ([n.sub.FL] = 176)   ([n.sub.FL] = 96)
                    ([n.sub.FM] = 80)    ([n.sub.FM] = 42)
                    (n = 256)            (n = 138)

esp-FL              114 (64.8)           58 (60.4)
esp-FM              2 (2.5)              4 (9.5)
esp-FL + esp-FM     116 (45.3)           62 (44.9)
agg                 76 (43.2)            42 (43.8)
asa1                16 (20.0)            12 (28.6)
agg + asal          92 (36.0)            54 (39.1)
ace                 114 (64.8)           52 (54.2)
acm                 56 (70.0)            30 (71.4)
ace + acm           170 (66.4)           82 (59.4)
efaA-FL             166 (94.3)           70 (72.9)
efaA-FM             74 (92.5)            36 (85.7)
efaA-FL + efaA-FM   240 (93.8)           106 (76.8)
eep-FL              174 (98.9)           90 (93.8)
eep-FM              N/A                  N/A
gelE-FL             146 (83.0)           78 (81.3)
gelE-FM             12 (15.0)            10 (23.8)
geIE-FL + geIE-FM   158 (61.7)           88 (63.7)
hyl-FL              48 (27.3)            22 (22.9)
hyl-FM              22 (27.5)            8 (19.0)
hyl-FL + hyl-FM     70 (27.3)            30 (21.7)
cylA-FL             110 (62.5)           62 (64.6)
cylA-FM             N/A                  N/A

Gene                Number (%) of isolates with the respective gene

                    Genital tract (a)   Blood
                    ([n.sub.FL] = 70)   ([n.sub.FL] = 18)
                    ([n.sub.FM] = 4)    ([n.sub.FM] = 8)
                    (n = 74)            (n = 26)

esp-FL              38 (54.3)           6 (33.3)
esp-FM              0 (0)               0 (0)
esp-FL + esp-FM     38 (51.4)           6 (23.1)
agg                 40 (57.1)           4 (22.2)
asa1                4 (100)             0 (0)
agg + asal          44 (59.5)           4 (15.4)
ace                 38 (54.3)           14 (77.8)
acm                 2 (50.0)            8 (100)
ace + acm           40 (54.1)           22 (84.6)
efaA-FL             58 (82.9)           12 (66.7)
efaA-FM             4 (100)             4 (50.0)
efaA-FL + efaA-FM   62 (83.8)           16 (61.5)
eep-FL              66 (94.3)           16 (88.9)
eep-FM              N/A                 N/A
gelE-FL             58 (82.9)           14 (77.8)
gelE-FM             2 (50.0)            0 (0)
geIE-FL + geIE-FM   60 (81.1)           14 (53.8)
hyl-FL              20 (28.6)           4 (22.2)
hyl-FM              2 (50)              2 (25.0)
hyl-FL + hyl-FM     22 (29.7)           6 (23.1)
cylA-FL             54 (77.1)           8 (44.4)
cylA-FM             N/A                 N/A

Gene                Number (%) of isolates with the respective gene

                    Others (b)          Total
                    ([n.sub.FL] = 10)   ([n.sub.FL] = 370)
                    ([n.sub.FM] = 6)    ([n.sub.FM] = 140)
                    (n = 16)            (n = 510)

esp-FL              4 (40.0)            220 (59.5)
esp-FM              0 (0)                6 (22.8)
esp-FL + esp-FM     4 (25.0)            226 (44.3)
agg                 2 (20.0)            164 (44.3)
asa1                0 (0)               32 (22.8)
agg + asal          2 (12.5)            196 (38.5)
ace                 8 (80.0)            226 (61.1)
acm                 6 (100)             102 (72.8)
ace + acm           14 (87.5)           328 (64.3)
efaA-FL             8 (80.0)            314 (84.9)
efaA-FM             6 (100)             124 (88.5)
efaA-FL + efaA-FM   14 (87.6)           438 (85.9)
eep-FL              8 (80.0)            354 (95.7)
eep-FM              N/A                 N/A
gelE-FL             8 (80.0)            304 (82.2)
gelE-FM             0 (0)               24 (17.1)
geIE-FL + geIE-FM   8 (50.0)            328 (64.3)
hyl-FL              0 (0)               94 (25.3)
hyl-FM              0 (0)               34 (24.2)
hyl-FL + hyl-FM     0 (0)               128 (25.1)
cylA-FL             6 (60.0)            240 (64.9)
cylA-FM             N/A                 N/A

FL, E. faecalis; FM, E. faecium; N/A, not
applicable for E. faecium. esp, gene for
enterococcal surface protein (adhesin) for both
species; agg, E. faecalis aggregation substance
involved in adherence to mammalian cells and
conjugation; asa1, E. faecium aggregation
substance involved in adherence to mammalian cells
and conjugation; ace, E. faecalis Ace
collagen-binding protein (adhesin); acm, E.
faecium Acm collagen-binding protein (adhesin);
efaA, cell wall adhesin expressed in patient serum
(endocarditis-specific antigen A) for both
species; eep (enhanced expression of pheromone),
membrane protein of E. faecalis; gelE,
extracellular metalloendopeptidase (gelatinase)
for both species; hyl, hyaluronidase for both
species; cylA, activation of cytolysin
(hemolysin/class I. bacteriocin) of E. faecalis.

(a) Genital tract specimens--sperm, urethral,
vaginal and cervical samples.

(b) others--peritoneal fluid (n = 6), bile (n =
2) and lower respiratory tract samples (n = 8).
COPYRIGHT 2016 Contexto
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Original article
Author:Strateva, Tanya; Atanasova, Daniela; Savov, Encho; Petrova, Guergana; Mitov, Ivan
Publication:The Brazilian Journal of Infectious Diseases
Article Type:Report
Geographic Code:4EXBU
Date:Mar 1, 2016
Words:4967
Previous Article:Are opossums a relevant factor associated with asymptomatic leishmania infection in the outskirts of the largest Brazilian cities?
Next Article:Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |